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1Chapter
Cross-Modality Dysfunction 
between the Visual and Olfactory 
Systems in Parkinson’s Disease
Motoyasu Honma
Abstract
Cross-modality in function is a fundamental ability in humans and is closely 
associated with the basic functions. Several studies have demonstrated that vision 
strongly influences other senses such as hearing, touch, taste, and smell. However, 
the dysfunction in this cross-modality caused by disease, is poorly understood. 
In addition to evidence that Parkinson’s disease (PD) impairs various cognitive 
functions including olfaction, a recent study showed that olfactory function is 
unaffected by visual information in patients with PD. This finding suggests that 
the link between vision and olfaction is underactive in PD. This chapter reviews the 
cross-modal dysfunction and dwells on the possibility of a novel precursor assess-
ment for PD.
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1. Introduction
Sensory organs independently process the corresponding external stimuli such 
as light, sound, pressure, taste, and smell. However, one sense rarely acts alone 
during the perception/cognition of a given event in daily life. Our experiences are 
dependent on the integration of the visual, auditory, somesthetic, gustatory, and 
olfactory systems. For example, during the act of smelling a strawberry, the sense 
of smell may vary according to the color of the strawberry (whether it is bright red 
or green-tinged), even if the physical odorant is the same (Figure 1). This example 
demonstrates that cognition is built upon cross-modality of function. The regions 
associated with cross-modality are spread throughout a wide area in brain [1]. For 
example, the integration of vision and touch is mainly associated with the right 
posterior fusiform gyrus and primary somatosensory cortices [2], whereas the 
integration of vision and audition is mainly associated with the right frontal lobe 
and right superior temporal gyrus [3].
The accuracy of each of the senses is different, and vision is often prioritized 
over other senses during integration. Several studies have demonstrated that 
visual input strongly influences hearing [4] touch [5], taste [6], and smell [7, 8] 
(Figure 2); however, the reverse, in which other senses influence vision, is a rare 
phenomenon, excluding the auditory-vision relationships such as the McGurk effect 
[9] or double flash illusion [10]. For the McGurk effect, on a video of audiovisual 
speech, if a lip movements show a “ba-ba” sound, whereas an auditory information 
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is that of “ga-ga”, most people experiences an illusory sound “da-da”. For the double 
flash illusion, if one dot flashes on the display when two beeps are sounded, most 
people reports experiencing two flashes. Thus, vision dominates the other senses in 
many cases. Although the mechanism of cross-modality has become increasingly 
clear in healthy persons [1–10], a function in disease states remains unclear.
2. Clinical state and cognitive dysfunction in Parkinson’s disease
Parkinson’s disease (PD) causes tremors of the hands, stiffness, akinesia, or 
inability to maintain posture. Patients with PD have decreased levels of dopamine 
in the striatum, which consists of the putamen and caudate nucleus, which are a 
part of the basal ganglia [11]. They may further develop protein-related disorders, 
Figure 2. 
Diagram representing the effective relationship among the five senses. Vision is often prioritized over the other 
senses during integration.
Figure 1. 
An example of the effect of color effect on smell recognition. The red strawberry on the left may seem to have a 
more pleasant odor than the green strawberry on the right.
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such as the presynaptic dopamine transporter (DaT), which is responsible for the 
incorporation and transmission of dopamine components [12]. DaT scanning is 
performed with ioflupane (123I-FP-CIT), a radio-iodinated cocaine analogue [13, 
14]. It has a high affinity for the DaT protein located on presynaptic nerve endings 
in the striatum. These nerve endings are projections of dopaminergic neurons 
from the substantia nigra. Binding of a radiopharmaceutical agent to DaT reflects 
number of striatal dopaminergic neurons. The accumulation of DaT is expressed in 
proportion to the occipital lobe (Figure 3). The degree of DaT deficit is associated 
with the severity of the movement disorder [15].
The principal symptoms of PD are related to movement, although the non-
motor symptoms are also noteworthy. For example, attention function, which 
demands a response speed or switching [16]; executive function, which is related 
to action planning or problem solving [17]; working memory function, which 
holds information temporarily and allocates attentional resources [18, 19]; social 
cognition function, which involves interpreting emotions based on others’ facial 
expressions [20, 21]; and temporal function, which estimates duration [22, 23] were 
shown to be impaired in PD.
Impairment of olfaction has also been reported in patients with PD and may be 
a biomarker for cognitive dysfunction and early PD [24–26]. Olfactory information 
is projected directly to the limbic system, including the piriform (PIR), amygdala 
(AMG), hippocampus (HI), and entorhinal cortex (ENT). These areas determine 
odor detection, its emotional evaluation (pleasant or unpleasant), and memory 
retrieval [27]. Olfactory information finally ascends to the orbitofrontal cortex 
(OFC). The OFC participates in the identification or recognition of odor, filtered 
through emotion and memory via activation of the AMG and HI [28]. Olfactory 
dysfunction in PD may occur due to deficiency of dopamine and pathological 
changes in the ENT, AMG and HI, especially in the areas affected by early onset of 
PD [29].
Furthermore, the striatum is involved in various functions, which include an 
integration of sensory information [30–32]. Studies have demonstrated that the 
striatum (putamen and caudate) acts as a “hub,” with specialized functional roles 
for different neuron types in mice [33] and humans [34, 35]. However, it was 
unclear whether PD affects cross-modal function.
Figure 3. 
Striatal DaT deficit in Parkinson’s disease (coronal view). The left panel shows a binding radiopharmaceutical 
agent accumulation in a healthy person. The right panel shows a binding radiopharmaceutical agent 
accumulation in a patient with Parkinson’s disease. The numbers indicate binding radiopharmaceutical agent 
counts on the striatum per pixel.
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3. Cross-modality dysfunction in Parkinson’s disease
Recently, a study showed that PD causes a decline in the cross-modal function of 
vision and olfaction [36]. This study conducted behavioral experiments to identify 
the influence of PD on cross-modal function by comparing the behavior of patients 
with PD with that of healthy controls. The principal aim of this study was to mea-
sure odor-strength perception and preference, while presenting smells paired with 
visual information, to characterize vision/olfaction integration in patients with PD.
In the experiment, odor detection thresholds in each participant were first 
determined using an olfactometer, which has five odorants (β-phenylethyl alcohol, 
methyl cyclopentenolone, isovaleric acid, γ-undecalactone, and skatole). For 
example, methyl cyclopentenolone smells like caramel pudding (pleasant) and 
skatole smells like rotten vegetables (unpleasant). The study employed detectable 
odorant thresholds in each of five categories and prepared five original pictures 
associated with the five odorants of each category. For example, the category 
“caramel pudding” consisted of a picture of “pudding” and the odorant “methyl 
cyclopentenolone,” whereas “rotten vegetables” consisted of “rotten vegetables” 
and the odorant “skatole” (Figure 4). The “control” category consisted of a noise 
picture and an odorless liquid. Four combinations were arranged: the original 
picture with the original odorant (combination “A”), the control picture with the 
original odorant (combination “B”), and the original picture with the control 
odorant (combination “C”). A control combination was added: the control picture 
with the control odorant (combination “D”) (Figure 5). Participants were asked 
take a sniff while viewing the picture, and were subsequently asked to evaluate the 
strength (weak – strong) and preference (pleasant – unpleasant) of each odor on a 
visual analog scale (VAS).
In the caramel pudding category, healthy controls overestimated the odor 
strength compared with patients with PD, when the original picture was presented 
(combinations A and C). Furthermore, healthy controls negatively estimated odor 
preference in combinations A and C in the “rotten vegetables” category (Figure 6). 
The results indicate that patients with PD accurately judged odor strength, without 
being distracted by visual appearance whereas odor strength/preference in healthy 
controls was influenced by visual appearance.
Furthermore, the study reported a possible effect of striatal DaT deficits in 
patients with PD on the olfaction-vision cross-modality. DaT imaging indicated 
that striatal DaT deficit in PD, especially that in the posterior putamen, is associated 
Figure 4. 
Examples of the category type. Each category consists of an original odorant and an original picture 
corresponding to the odorant, and a control category consisting of a noise picture and an odorless liquid (this 
figure is cited with edit from a part of Honma et al. [36]).
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with the cross-modal effect of perception on odor preference, and the laterality may 
depend on the emotional category (pleasant or unpleasant) (Figure 7).
4.  Possible mechanism of dysfunctional cross-modality between vision 
and olfaction
Honma et al. [36] showed that the olfactory function was unaffected by visual 
information in patients with PD, supporting the hypothesis that PD impairs 
cross-modality between vision and olfaction [36]. Healthy participants tend to 
Figure 5. 
Combinations of the pictures and odorants. Combination a includes the original picture and original odorant. 
Combination B includes the control picture and original odorant. Combination C includes the original picture 
and the control odorant. Combination D includes the control picture and control odorant (this figure is cited 
with edit from a part of Honma et al. [36]).
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overestimate odor when presented with an original picture, for example, a picture 
of caramel pudding without the methyl cyclopentenolone odorant, will be perceived 
as pleasant. In contrast, patients with PD tend to concentrate more on smell, rather 
than the influence of visual stimuli. The odor estimate is independent of vision in 
patients with PD.
Figure 6. 
(A) Strength of the odor represented on the visual analog scale. (B) Preference for odor on the visual 
analog scale. The visual analog scale scores of the groups (healthy controls and participants with PD) and 
combinations (A, B, and C) were compared for each category. The control category (combination D) was 
analyzed independently. Asterisks indicate significant differences. These results show that the visual input 
affects odor estimation in healthy controls, with little effect in PD (this figure is cited with edit from a part of 
Honma et al. [36]).
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Olfactory perception is ambiguous, and a smell may be hard to identify without 
verbal or visual assistance. It is true that olfaction is modulated by visual elements 
[7, 8]. This multimodal integration is responsible for the OFC, which receives 
information from visual association, and the olfactory, gustatory, somatosensory 
and, auditory areas [37]. Recent brain imaging studies showed that the OFC 
participates in vision-olfaction integration in healthy individuals [7]. Gottfried and 
Dolan (2003) noted higher activation of the OFC when a smell is presented with a 
word label [7]. Cognitive factors, such as visual stimuli modulate representations 
of odor at a relatively early level of cortical processing, known as the top-down 
cognitive influence, which directly affects emotion [38]. Healthy participants 
exhibited dominance of the visual sense in this study. On the other hand, patients 
with PD exhibited decrease dominance of visual information. They concentrated 
more on olfactory perception, without modulation from visual input. The OFC in 
patients with PD is known to be less active for all modalities during stimulation, 
including olfaction [39]. Decreased activation of the OFC in patients with PD may 
partly account for declining cross-modality. Moreover, detection and cognition 
levels for odor were lower than those in the controls. During olfaction, the OFC also 
integrates information from the AMG and HI, which play a role in emotional evalu-
ation and memory retrieval [37]. Reduction of OFC function may lead to deficits 
in recognition and identification of odor. Thus, patients with PD may tend to focus 
more on smell detection, which may need activation of the basic primary olfactory 
areas, such as the ENT and PIR.
The relationship of DaT levels in PD with odor preferences demonstrated by the 
study is significant. However, it has been reported that administration of dopamine 
agonists (levodopa) does not influence the olfactory deficit. Thus, dopamine loss 
may not affect olfaction [40]. Here, it was not possible to establish a direct link 
between olfaction and dopamine levels, as measured by DaT in the putamen. 
However, earlier findings suggest that the putamen may play a role in sensory inte-
gration [34, 35]. Lack of dopamine linked to deficient DaT protein in the striatum 
leads to a decline in dopamine levels in several regions [41]. The corticostriatal loop 
sends signals that pass through brain regions, such as the striatum–pallidus–tha-
lamic–cortex [42]. Dopamine regulates the prefrontal-AMG circuit, which plays an 
important role in emotion processing [43]. This suggests that vision-olfaction inte-
gration may be influenced by dopamine signals, via a striatum-centered network. 
Figure 7. 
Regression analysis identified the left posterior putamen as the independent variable for the cross-modal effects 
of pleasant categories (caramel pudding, fresh roses, and canned peaches). The right posterior putamen was 
identified as the independent variable for the cross-modal effects of unpleasant categories (rotten vegetables 
and dirty socks). The laterality in putamen may depend on emotionality.
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Dopamine deficiency in PD may affect vision-olfaction integration, including 
emotion and cognitive processing.
The laterality of DaT level in the putamen related to odor preference is of further 
interest. That is, the left is associated with pleasant smells and the right is associated 
with unpleasant smells. A recent study has shown that a pleasant odor is associated 
with bilateral or left AMG activation, and an unpleasant odor is associated with 
activation of the right AMG [27]. The left/right difference for smell-evoked emo-
tion may be linked to AMG processing, because these regions are strongly con-
nected at a fiber level [44].
5. Conclusion
It is essential to investigate the onset of cross-modality dysfunction in the future. 
Studies are currently focusing on early detection of PD, including signs of declining 
olfactory ability and rapid eye movement-related sleep disorders, as precursory bio-
markers for PD [24–26, 45]. This approach may provide a new view of precursors, 
if the dysfunction develops before onset of movement disorders in PD (Figure 8). 
Furthermore, it is necessary to examine whether cross-modal dysfunction occurs 
in other diseases with striatum deficit, such as multiple system atrophy [46] and 
Huntington’s disease [47]. Cross-modal dysfunction may also lead to diagnoses of 
other diseases.
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Figure 8. 
Conceivable onsets of cross-modality dysfunction. Declining olfactory ability and rapid eye movement-related 
sleep disorder are known to be precursory biomarkers for Parkinson’s disease. Cross-modality dysfunction also 
has the potential of becoming a novel biomarker.
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